Dr. Portlock specializes in the care of patients with Hodgkin and non-Hodgkin lymphoma, and she is board-certified in internal medicine and medical oncology. She collaborates with her colleagues to conduct clinical trials aimed at improving the outcome of patients with these diseases through the development and evaluation of new treatment regimens. She has become internationally known in her field, having served as a previous member of the Board of Scientific Counselors of the National Cancer Institute and the Oncologic Drug Advisory Committee of the US Food and Drug Administration.
She is currently a member of the American Society of Clinical Oncology and the American Society of Hematology. She has received several awards for her work, including the Evelyn Hoffman Memorial Award from the Lymphoma Research Foundation of America and the Ettinger Prize from the American Cancer Society’s Connecticut Division.
- Clinical Expertise: Lymphomas and Hodgkin Disease
- Languages Spoken: English
- Education: MD, Stanford University
- Residencies: Medicine - Stanford University Hospital
- Fellowships: Stanford University Medical Center
- Board Certifications: Internal Medicine; Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more